Erratum: the efficacy of cancer immunotherapies is compromised by helicobacter pylori infection

HIGHLIGHTS

• who: Frontiers Production Office from the Media SA, Switzerland have published the research work: Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection, in the Journal: (JOURNAL)

SUMMARY

Helicobacter pylori, cancer, immunotherapy, personalized medicine, gut microbiota, immune checkpoint inhibitors ACCEPTED CITATION Frontiers Production Office Erratum. The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection. 14:1183107. doi: 10.3389/fimmu.2023.1183107 COPYRIGHT Frontiers in Immunology The efficacy of cancer immunotherapies Helicobacter pylori infection is compromised by by Oster P, Vaillant L, McMillan B and Velin D Front . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.